Fundz

Dr. Chris Bahl Appointed as Chief Executive Officer of AI Proteins, Inc., Succeeding Noah Beerman

PRIVATEJan 08, 2025

Company

AI Proteins

BostonBiotechnologyArtificial Intelligence

Description

Dr. Chris Bahl, the founder, President, and Chief Scientific Officer of AI Proteins, Inc., has been appointed as the Chief Executive Officer, succeeding Noah Beerman. Dr Bahl will lead the company into its next phase, advancing its innovative platform and pipeline of groundbreaking therapies.

Quick answer

Dr. Chris Bahl Appointed as Chief Executive Officer of AI Proteins, Inc., Succeeding Noah Beerman (January 8, 2025). AI Proteins is based in Boston, Massachusetts, United States.

What did AI Proteins announce on January 8, 2025?
Dr. Chris Bahl, the founder, President, and Chief Scientific Officer of AI Proteins, Inc., has been appointed as the Chief Executive Officer, succeeding Noah Beerman. Dr Bahl will lead the company into its next phase, advancing its innovative platform and pipeline of groundbreaking therapies.
What does AI Proteins do?
AI Proteins is a Boston-based biotech company reimagining protein therapeutics through AI-enabled design and a high-throughput discovery platform.
Where is AI Proteins based?
AI Proteins is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Oxford Cancer Analytics (January 9, 2025), Alltrna (January 6, 2025), Basecamp Research (January 6, 2025) and Eko Health (January 9, 2025) also announced leadership changes within 45 days of AI Proteins.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Artificial Intelligence

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AI Proteins, and when

A new leader at AI Proteins brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AI Proteins raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AI Proteins, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AI Proteins. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AI Proteins

Location

20 Overland St.

Boston, Massachusetts, United States

About

AI Proteins is a Boston-based biotech company reimagining protein therapeutics through AI-enabled design and a high-throughput discovery platform. The company creates entirely de novo miniproteins optimized for diverse therapeutic applications and partners with leading biopharmaceutical companies while advancing its own pipeline. Its platform dramatically accelerates the development of lead candidates ready for IND-enabling studies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AI Proteins changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chris
Senior decision-maker at this company
••••••••@••••••••

See Chris's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AI Proteins's next move

Learn about Strategic plan

AI Proteins changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.